Amendment to the Amended and Restated Employment Agreement (May 2nd, 2017)
This Amendment ("Amendment"), effective as of April 28, 2017 (the "Effective Date"), by and between Acceleron Pharma Inc., a Delaware corporation ("Acceleron"), and Steven D. Ertel (the "Executive"), amends that certain Amended and Restated Employment Letter between Executive and Acceleron, dated as of January 31, 2014, as amended (the "Agreement"). Together Acceleron and Executive are the "Parties" and each is a "Party". All capitalized terms used in this Amendment but not defined shall have the meanings ascribed to them in the Agreement.
COLLABORATION, LICENSE AND OPTION AGREEMENT by and Between ACCELERON PHARMA, INC. And CELGENE CORPORATION (August 4th, 2016)
This Collaboration, License and Option Agreement (this "Agreement") dated the 20th day of February, 2008 (the "Execution Date") is by and between Acceleron Pharma, Inc., a Delaware corporation having its principal office at 149 Sidney Street, Cambridge, MA 02139 ("Acceleron"), and Celgene Corporation, a Delaware corporation having its principal office at 86 Morris Avenue, Summit, NJ 07901 ("Celgene"). Acceleron and Celgene may each be referred to herein individually as a "Party" and collectively as the "Parties."